220 related articles for article (PubMed ID: 2430691)
1. Analysis of receptors, cell surface antigens, and proteins in human melanoma cell lines resistant to human recombinant beta- or gamma-interferon.
Gomi K; Akinaga S; Oka T; Morimoto M
Cancer Res; 1986 Dec; 46(12 Pt 1):6211-6. PubMed ID: 2430691
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.
Ziai MR; Imberti L; Tongson A; Ferrone S
Cancer Res; 1985 Nov; 45(11 Pt 2):5877-82. PubMed ID: 3931909
[TBL] [Abstract][Full Text] [Related]
3. Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells.
Fisher PB; Hermo H; Solowey WE; Dietrich MC; Edwalds GM; Weinstein IB; Langer JA; Pestka S; Giacomini P; Kusama M
Anticancer Res; 1986; 6(4):765-74. PubMed ID: 2944474
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of antiviral and anticellular activities of human recombinant interferon-gamma.
Gomi K; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1985 Mar; 76(3):224-34. PubMed ID: 3922841
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons.
Giacomini P; Gambari R; Barbieri R; Nisticò P; Tecce R; Pestka S; Gustafsson K; Natali PG; Fisher PB
Anticancer Res; 1986; 6(5):877-84. PubMed ID: 2432832
[TBL] [Abstract][Full Text] [Related]
6. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential.
Maio M; Gulwani B; Langer JA; Kerbel RS; Duigou GJ; Fisher PB; Ferrone S
Cancer Res; 1989 Jun; 49(11):2980-7. PubMed ID: 2497970
[TBL] [Abstract][Full Text] [Related]
7. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
Andrews PW; Trinchieri G; Perussia B; Baglioni C
Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
[TBL] [Abstract][Full Text] [Related]
8. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
Wietzerbin J; Gaudelet C; Aguet M; Falcoff E
J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of recombinant human leukocyte interferons on cell surface antigen expression.
Greiner JW; Fisher PB; Pestka S; Schlom J
Cancer Res; 1986 Oct; 46(10):4984-90. PubMed ID: 2944575
[TBL] [Abstract][Full Text] [Related]
10. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
[TBL] [Abstract][Full Text] [Related]
11. The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells.
Okabe M; Gomi K; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1985 Jul; 76(7):608-17. PubMed ID: 3928557
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
Shaw AR; Chan JK; Reid S; Seehafer J
J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines.
Miracco C; Maellaro E; Pacenti L; Del Bello B; Valentini MA; Rubegni P; Pirtoli L; Volpi C; Santopietro R; Tosi P
Int J Oncol; 2003 Jul; 23(1):213-20. PubMed ID: 12792796
[TBL] [Abstract][Full Text] [Related]
14. Modulation by recombinant DNA leukocyte (alpha) and fibroblast (beta) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells.
Giacomini P; Aguzzi A; Pestka S; Fisher PB; Ferrone S
J Immunol; 1984 Sep; 133(3):1649-55. PubMed ID: 6747299
[TBL] [Abstract][Full Text] [Related]
15. Synergistic anticellular and antiviral activities of human recombinant interferon-gamma and -beta.
Gomi K; Kimura H; Okabe M; Oka T; Morimoto M
J Pharmacobiodyn; 1986 Nov; 9(11):871-8. PubMed ID: 3031263
[TBL] [Abstract][Full Text] [Related]
16. Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells.
Schiller JH; Bushmeyer SM; Ruzicka FJ; Princler GL; Faltynek CR; Borden EC
Cancer Res; 1990 Jan; 50(1):26-31. PubMed ID: 2136700
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis.
Schiller JH; Groveman DS; Schmid SM; Willson JK; Cummings KB; Borden EC
Cancer Res; 1986 Feb; 46(2):483-8. PubMed ID: 2416427
[TBL] [Abstract][Full Text] [Related]
18. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
[TBL] [Abstract][Full Text] [Related]
19. Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.
Bae SI; Cheriyath V; Jacobs BS; Reu FJ; Borden EC
Oncogene; 2008 Jan; 27(4):490-8. PubMed ID: 17653094
[TBL] [Abstract][Full Text] [Related]
20. Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma-associated surface antigens.
Murray JL; Stuckey SE; Pillow JK; Rosenblum MG; Gutterman JU
J Biol Response Mod; 1988 Apr; 7(2):152-61. PubMed ID: 3129542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
